285 related articles for article (PubMed ID: 24122036)
1. Chemotherapy-induced cardiovascular toxicity: beyond anthracyclines.
Ai D; Banchs J; Owusu-Agyemang P; Cata JP
Minerva Anestesiol; 2014 May; 80(5):586-94. PubMed ID: 24122036
[TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular complications of chemotherapy].
Tovena DM; Inzoli A; Donato G; Gazzaniga P; Bianchessi C
G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):165S-170S. PubMed ID: 23096398
[TBL] [Abstract][Full Text] [Related]
3. Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy.
Raschi E; Vasina V; Ursino MG; Boriani G; Martoni A; De Ponti F
Pharmacol Ther; 2010 Feb; 125(2):196-218. PubMed ID: 19874849
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity: anthracyclines and long term cancer survivors.
Patanè S
Int J Cardiol; 2014 Oct; 176(3):1326-8. PubMed ID: 25129289
[No Abstract] [Full Text] [Related]
5. Prevention and management of cardiotoxicity from antineoplastic therapy.
Chanan-Khan A; Srinivasan S; Czuczman MS
J Support Oncol; 2004; 2(3):251-6; discussion 259-61, 264-6. PubMed ID: 15328825
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced cardiotoxicity: detection, prevention, and management.
Truong J; Yan AT; Cramarossa G; Chan KK
Can J Cardiol; 2014 Aug; 30(8):869-78. PubMed ID: 25064580
[TBL] [Abstract][Full Text] [Related]
7. Anthracycline cardiotoxicity in childhood.
Ruggiero A; Ridola V; Puma N; Molinari F; Coccia P; De Rosa G; Riccardi R
Pediatr Hematol Oncol; 2008 Jun; 25(4):261-81. PubMed ID: 18484471
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological foundations of cardio-oncology.
Minotti G; Salvatorelli E; Menna P
J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
[TBL] [Abstract][Full Text] [Related]
9. Predicting and preventing the cardiotoxicity of cancer therapy.
Anderson B; Sawyer DB
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1023-33. PubMed ID: 18666852
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of systemic cancer treatment.
Senkus E; Jassem J
Cancer Treat Rev; 2011 Jun; 37(4):300-11. PubMed ID: 21126826
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
Nelson-Veniard M; Thambo JB
Bull Cancer; 2015; 102(7-8):622-6. PubMed ID: 25935231
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity of systemic agents used in breast cancer.
Ades F; Zardavas D; Pinto AC; Criscitiello C; Aftimos P; de Azambuja E
Breast; 2014 Aug; 23(4):317-28. PubMed ID: 24794210
[TBL] [Abstract][Full Text] [Related]
13. Heart failure and chemotherapeutic agents.
Piper S; McDonagh T
Future Cardiol; 2015 Jul; 11(4):453-70. PubMed ID: 26234158
[TBL] [Abstract][Full Text] [Related]
14. Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies.
Sethi TK; Basdag B; Bhatia N; Moslehi J; Reddy NM
Curr Hematol Malig Rep; 2017 Jun; 12(3):257-267. PubMed ID: 28233150
[TBL] [Abstract][Full Text] [Related]
15. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
16. Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.
O'Hare M; Sharma A; Murphy K; Mookadam F; Lee H
Expert Rev Cardiovasc Ther; 2015 May; 13(5):511-8. PubMed ID: 25843285
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
Yeh ET; Tong AT; Lenihan DJ; Yusuf SW; Swafford J; Champion C; Durand JB; Gibbs H; Zafarmand AA; Ewer MS
Circulation; 2004 Jun; 109(25):3122-31. PubMed ID: 15226229
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-related cardiotoxicity.
Aggarwal S; Kamboj J; Arora R
Ther Adv Cardiovasc Dis; 2013 Apr; 7(2):87-98. PubMed ID: 23487044
[TBL] [Abstract][Full Text] [Related]
19. Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs.
Jones RL; Ewer MS
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1249-69. PubMed ID: 17020459
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular toxicity of some cancer agents (others than anthracyclines, fluoropyrimidines and trastuzumab)].
Saintigny P; Chouahnia K; Charniot JC; Breau JL
Bull Cancer; 2004 Nov; 91 Suppl 3():174-84. PubMed ID: 15899625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
